Evidence map›Paper›PMID 31548790›Full record

ReviewTopics in spinal cord injury rehabilitation2019

Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Ana Flores-Mireles, Teri N Hreha, David A Hunstad

Open access · bronzeAbstract readReview
In one paragraph

Review in Topics in spinal cord injury rehabilitation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. UropathogenicAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The unique Efg1 fungal virulence regulon in the catheterized bladder environment.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Preventive action of ketamine alone and in combination with antifungals on Candida biofilm formation in catheters.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Smart Catheters for Diagnosis, Monitoring, and Therapy.Advanced healthcare materials · 2026
    Review
  17. Fabrication of bioprints self-coated with thermally sensitive lactobacilli for CAUTI applications.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2026
    Article
  18. Chondroitin sulfate degradation bolstersbioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ana Flores-MirelesUniversity of Notre Dame, Notre Dame, Indiana.
Teri N HrehaWashington University School of Medicine, Saint Louis, Missouri.
David A HunstadWashington University School of Medicine, Saint Louis, Missouri.
Washington University in St. Louis · USUniversity of Notre Dame · US

Funding

ANDROGEN INFLUENCE ON UTI SUSCEPTIBILITY AND SEVERITYR01DK111541 · NIDDK · WASHINGTON UNIVERSITY · PI HUNSTAD, DAVID · 2018 to 2021
$1.4M
NIDDK NIH HHS R01 DK111541
6 · The paper itself

Abstract

Urinary tract infections (UTIs) are among the most common microbial infections in humans and represent a substantial burden on the health care system. UTIs can be uncomplicated, as when affecting healthy individuals, or complicated, when affecting individuals with compromised urodynamics and/or host defenses, such as those with a urinary catheter. There are clear differences between uncomplicated UTI and catheter-associated UTI (CAUTI) in clinical manifestations, causative organisms, and pathophysiology. Therefore, uncomplicated UTI and CAUTI cannot be approached similarly, or the risk of complications and treatment failure may increase. It is imperative to understand the key aspects of each condition to develop successful treatment options and improve patient outcomes. Here, we will review the epidemiology, pathogen prevalence, differential mechanisms used by uropathogens, and treatment and prevention of uncomplicated UTI and CAUTI.

Indexed as

Anti-Bacterial AgentsCatheter-Related InfectionsHumansImmunotherapyImmunotherapy, ActiveUrinary Tract InfectionsAnti-Bacterial AgentsCAUTIprevalencesusceptibilityuncomplicated UTIuropathogens

Identifiers

PMID31548790
PMCPMC6743745
OpenAlexW2972970051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.